Cargando…

Side chain effect in the modulation of α(v)β(3)/α(5)β(1) integrin activity via clickable isoxazoline-RGD-mimetics: development of molecular delivery systems

Construction of small molecule ligand (SML) based delivery systems has been performed starting from a polyfunctionalized isoxazoline scaffold, whose α(v)β(3) and α(5)β(1) integrins’ potency has been already established. The synthesis of this novel class of ligands was obtained by conjugation of link...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrazzano, Lucia, Corbisiero, Dario, Potenza, Eleonora, Baiula, Monica, Dattoli, Samantha Deianira, Spampinato, Santi, Belvisi, Laura, Civera, Monica, Tolomelli, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198601/
https://www.ncbi.nlm.nih.gov/pubmed/32366988
http://dx.doi.org/10.1038/s41598-020-64396-4
Descripción
Sumario:Construction of small molecule ligand (SML) based delivery systems has been performed starting from a polyfunctionalized isoxazoline scaffold, whose α(v)β(3) and α(5)β(1) integrins’ potency has been already established. The synthesis of this novel class of ligands was obtained by conjugation of linkers to the heterocyclic core via Huisgen-click reaction, with the aim to use them as “shuttles” for selective delivery of diagnostic agents to cancer cells, exploring the effects of the side chains in the interaction with the target. Compounds 17b and 24 showed excellent potency towards α(5)β(1) integrin acting as selective antagonist and agonist respectively. Further investigations confirmed their effects on target receptor through the analysis of fibronectin-induced ERK1/2 phosphorylation. In addition, confocal microscopy analysis allowed us to follow the fate of EGFP conjugated α(5)β(1) integrin and 17b FITC-conjugated (compound 31) inside the cells. Moreover, the stability in water solution at different values of pH and in bovine serum confirmed the possible exploitation of these peptidomimetic molecules for pharmaceutical application.